SB
Sisent Badri Narayan Patra
About Sisent Badri Narayan Patra
Data last updated:
Sisent Badri Narayan Patra is a Director at Health Plus Pharmaceutical Private Limited (since 2025). Health Plus Pharmaceutical Private Limited reported revenue of ₹5,600 (FY 2026). Earlier, Sisent Badri Narayan Patra was a Director at Vanijya Bharat Marketing Private Limited (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jul 2025 | 2025 | ₹5,600 (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Nov 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sisent Badri Narayan Patra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sadan Mali | 08057976 | Health Plus Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sisent Badri Narayan Patra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sisent Badri Narayan Patra
Sisent Badri Narayan Patra currently holds 1 directorship: Health Plus Pharmaceutical Private Limited (Director, since 05 Jul 2025, revenue ₹5,600 (FY 2026)).
Sisent Badri Narayan Patra was first appointed on 29 Nov 2018 as Director at Vanijya Bharat Marketing Private Limited. The most recent appointment on record is 05 Jul 2025 at Health Plus Pharmaceutical Private Limited.
Sisent Badri Narayan Patra held 1 earlier board appointment: Vanijya Bharat Marketing Private Limited (Director, from 29 Nov 2018).
The current boards of Sisent Badri Narayan Patra's companies include Sadan Mali (Health Plus Pharmaceutical Private Limited).